Advanced search×

Detection of second malignancies during long-term follow-up of testicular cancer survivors.

Tomas T Buchler, Petra P Kubankova, Ludmila L Boublikova, Zuzana Z Donatova, Martin M Foldyna, Jana J Kanakova, Drahomira D Kordikova, Martin M Kupec, Jana J Nepomucka, Eva E Vorsilkova, and Jitka J Abrahamova

Cancer 117(18):4212-8 (2011) PMID 21480199

Second cancers are an important cause of mortality and morbidity in long-term survivors of testicular germ cell tumors (TGCTs). Studies on the impact of follow-up for the first tumor on the outcome of second malignancies are lacking. The aim of this study was to study the details of diagnosis of second cancers and the role of focused oncology follow-up.

DOI: 10.1002/cncr.26039
Version: za2963e q8za7 q8zb6 q8zc2 q8zdc q8ze2 q8zf5 q8zg8

Similar articles you may find interesting…

  1. Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer.
    Susanna V Ulahannan and Julie R Brahmer

    Cancer Invest 29(4):325-37 (2011) PMID 21469981 PMCID PMC3082199

    We review current clinical data with combination therapy involving antiangiogenic agents and cytotoxic chemotherapy in patients with advanced NSCLC....
    View PDF
  2. Ultrasound and ultrasound guided biopsy, CT and lymphography in the diagnosis of retroperitoneal metastases in testicular cancer.
    K K Damgaard-Pedersen and H H von der Maase

    Scand J Urol Nephrol Suppl (1991) PMID 1947835

    A retrospective study of bipedal lymphography (BL), computed tomography (CT) and ultrasonography (US) of retroperitoneal lymph nodes has been carried out in 95 patients with newly diagnosed testicular cancer. Twenty-one patients had abnormal lymph nodes at the time of staging. The diagnostic accurac...
  3. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer.
    F A FA Critz, W H WH Williams, ... D A DA Holladay

    J Urol 163(4):1085-9 (2000) PMID 10737471

    PSA bounce is common following seed implantation for prostate cancer. It produces anxiety in men previously treated for prostate cancer and confounds the diagnosis of recurrence....